9-(5-Bromo-2-hy­droxy­phen­yl)-10-(2-hy­droxy­prop­yl)-3,3,6,6-tetra­methyl-1,2,3,4,5,6,7,8,9,10-deca­hydro­acridine-1,8-dione

The dihydro­pyridine ring in the title compound, C(26)H(32)BrNO(4), adopts an envelope conformation with the methine C atom representing the flap. The cyclo­hexenone rings also adopt envelope conformations. The phenolic hy­droxy group forms an intra­molecular hydrogen bond to one of the two keto O a...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalilov, Ali N., Abdelhamid, Antar A., Gurbanov, Atash V., Ng, Seik Weng
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2011
Materias:
Organic Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089333/
https://www.ncbi.nlm.nih.gov/pubmed/21754454
http://dx.doi.org/10.1107/S1600536811013481
Descripción
Sumario:The dihydro­pyridine ring in the title compound, C(26)H(32)BrNO(4), adopts an envelope conformation with the methine C atom representing the flap. The cyclo­hexenone rings also adopt envelope conformations. The phenolic hy­droxy group forms an intra­molecular hydrogen bond to one of the two keto O atoms. Inter­molecular weak C—H⋯O hydrogen bonding is present in the crystal structure. The hy­droxy­propyl group is disordered over two sets of sites with an occupancy ratio of 0.636 (6):0.364 (6).

Ejemplares similares